Ozempic-Maker CEO Ousted Over Pharma Company’s Rocky Market Downturn

In a sharp and surprising twisting, CEO Ozempical manufacturer Novo Nordisk was fired as the head of the company. Denmark Pharmaceutical Giant Friday, in the company’s shares, Lars Frugaard Jørgensen would look for a successor for him, the best executive and plaques soon.

As long as mutual agreement with the Novo Nordisk Council, Lars Frugaard Jørgensen will be relieved of the post of CEO of Novo Nordiskin, “he said. The company made a press release. “He will continue as General Director for a while to support a smooth passage to the new leadership.”

Undoubtedly, Novo thinks that Nordiskin is not very good. After all, this is an seemingly visible dissarentic medication, the company of Semaglutide Jim Gaffigan OprahImmediate pounds. Again, while providing status as Ozempic and Wegovy global home names, Novo saw Nordisk stock price Significant retardation As last year Rival brands they do not enter the market. In a statement on the exhibition of Jorgensen, the pharmaceutical company is the thing that causes a fast-changing landscape to lose weight. “Recent market problems faced by the Novo Nordisk, changes in the development of the company’s share price since mid-2024 Press release is read from the company.

At the same time, Jorgensen has managed to become better economic waters during a decade before launching in 2024, “Given the company’s recent market problems, sharing stock price and Novo Nordisk Foundation and Lars Frugaard Jørgensen came out of the Novo Nordisk Foundation and Lars FrugAld Jørgensen.

Gizmodo has reached Novo Nordisk for more information and will update this story if answers.